-
Mashup Score: 1
Just over a century ago, much of the U.S. population experienced disfiguring and debilitating disorders related to iodine deficiency. In 2024, we celebrate 100 years of salt iodization — a tremendous public health achievement.Soils across much of the upper Midwest and Pacific Northwest and throughout the Appalachians are poor in iodine, which resulted in iodine-deficient diets for humans
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Hearing loss with teprotumumab more likely for adults with baseline hearing dysfunction - 11 month(s) ago
Hearing loss occurred more frequently among adults who received teprotumumab for the treatment of thyroid eye disease if they had impaired hearing at the start of therapy, according to a research letter published in Thyroid. In a small prospective cohort study, one adult out of 32 (3%) with normal hearing at baseline developed hearing decline after a full, 24-week course of teprotumumab-trbw
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
👂Hearing loss for adults receiving teprotumumab for #thyroid eye disease is more common for people who have hearing dysfunction prior to the start of treatment. Read more 👇 @LiebertPub @Healio_OSN https://t.co/Pbu4zlGn1t
-
-
Mashup Score: 0Hearing loss with teprotumumab more likely for adults with baseline hearing dysfunction - 11 month(s) ago
Hearing loss occurred more frequently among adults who received teprotumumab for the treatment of thyroid eye disease if they had impaired hearing at the start of therapy, according to a research letter published in Thyroid. In a small prospective cohort study, one adult out of 32 (3%) with normal hearing at baseline developed hearing decline after a full, 24-week course of teprotumumab-trbw
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
👂Hearing loss for adults receiving teprotumumab for #thyroid eye disease is more common for people who have hearing dysfunction prior to the start of treatment. Read more 👇 @LiebertPub @Healio_OSN https://t.co/Pbu4zlGn1t
-
-
Mashup Score: 0
ChatGPT correctly answered more than two-thirds of submitted questions about thyroid nodules, though its responses may be at a grade level too high for patient education, according to study findings published in Thyroid. “Whether the authors think that ChatGPT could be reliably used by patients or not, we find it inevitable that it will be,” Daniel J. Campbell, MD, an otolaryngologist
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
🖥️@ChatGPTBot accurately answers most patient education questions on #thyroid nodules, but gives responses at a reading level that may be too high for some patients to understand. Read more 👇 @Jefferson_OTO @TJUHospital https://t.co/DDlZG2yo35
-
-
Mashup Score: 0
ChatGPT correctly answered more than two-thirds of submitted questions about thyroid nodules, though its responses may be at a grade level too high for patient education, according to study findings published in Thyroid. “Whether the authors think that ChatGPT could be reliably used by patients or not, we find it inevitable that it will be,” Daniel J. Campbell, MD, an otolaryngologist
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
🖥️@ChatGPTBot accurately answers most patient education questions on #thyroid nodules, but gives responses at a reading level that may be too high for some patients to understand. Read more 👇 @Jefferson_OTO @TJUHospital https://t.co/DDlZG2yo35
-
-
Mashup Score: 0Radiofrequency ablation eliminates tumor for most adults with low-risk thyroid cancer - 1 year(s) ago
More than 95% of adults with low-risk papillary thyroid cancer were disease-free after radiofrequency ablation, according to findings from a single-center study published in Thyroid. “Ultrasound-guided radiofrequency ablation is effective for treating of small unifocal low-risk papillary thyroid cancer, with 96.1% technical efficacy by core-needle biopsy pathological examination and 91.6%
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
📰 Radiofrequency ablation may be an effective strategy for treating low-risk papillary #thyroid cancer, according to researchers from a single center in China. Read more⤵️@LiebertPub https://t.co/AKI8oyMmMu
-
-
Mashup Score: 4Hemithyroidectomy linked to better quality of life for adults with low-risk thyroid cancer - 1 year(s) ago
Hemithyroidectomy is associated with better quality of life after surgery than total thyroidectomy for adults with low-risk differentiated thyroid cancer, though more studies are needed, according to findings from a systematic review. “The long-term data are mixed on how the extent of surgery affects health-related quality of life in patients with low-risk differentiated thyroid
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
📰A systematic review reveals adults who undergo surgery after being diagnosed with low-risk differentiated #thyroid cancer may have better quality of life if they have a hemithyroidectomy. Read more 👇 @susieQP8 @UMichSurgery @HemOncToday https://t.co/S2g2kKrnjN
-
-
Mashup Score: 3Illustrating the Progression of Thyroid Eye Disease - 1 year(s) ago
Thyroid Eye Disease often causes quality-of-life changes for patients. Endocrinologist Malini Gupta, MD, demonstrates the structural changes of thyroid eye disease in this series of images.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet-
RT @DrKarlNadolsky: Amazing work by @MaliniGuptaMD Illustrating the Progression of #Thyroid Eye Disease using food https://t.co/lzEJq5zrjt…
-
-
Mashup Score: 2
Click on the article title to read more.
Categories: General Medicine News, Onc News and JournalsTweet-
New CytoSource: our 2nd of a 2-part series examines the struggle to balance preventive care costs vs. benefits, and the lessons of #thyroid cancer overdiagnosis and overtreatment. https://t.co/hxns6HxP6X @seattlebryn @bfaquin https://t.co/M1j1yMHdbN
-
-
Mashup Score: 1
Exposure to a class of endocrine-disrupting chemicals may increase the risk for developing thyroid cancer, according to a study published in eBioMedicine. In a nested case-control study, researchers analyzed exposure to PFAS among adults diagnosed with thyroid cancer and those without thyroid cancer. Adults had a higher likelihood for developing thyroid cancer with greater exposure to linear
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet-
Exposure to higher levels of PFAS, a class of endocrine-disrupting chemicals, may increase one’s risk for developing #thyroid cancer. Read more 👇 @mountsinainyc @HemOncToday https://t.co/rwpSTWgBnk
-
🧂This year marks the 100th anniversary of salt iodization. Elizabeth Pearce, MD, MSc, discusses the origins of iodized salt and how it has a major impact on #thyroid health and public health as a whole. @BUSPH Read more 👇 https://t.co/sYs1TG8HNJ